Get a Quote

Request a PGx Demo

Get a Quote

01603 327 053

PGx Testing

Services

About

Resources

01603 327 053

Pharmacogenomics Services

Get a Quote
Tell us about your testing requirements

Your Guide to Personalised Healthcare

Learn from the AttoDiagnostics blog.

How DNA-Driven Prescriptions Could Save the NHS over £530M Annually

Published 27/03/2025

Every year, adverse drug reactions (ADRs) account for 6.5% of hospital admissions in the UK, costing the NHS an estimated £530 million annually. These preventable incidents burden an already overstretched healthcare system and impact patients' lives with prolonged recovery times and unnecessary suffering. But, what if there were a way to eliminate this trial-and-error approach to prescribing? Enter pharmacogenomics: the future of personalised medicine.

PGx Testing and AttoDiagnostics

Published 13/03/2025

When someone isn’t feeling well, there are many factors to consider. A typical approach by a healthcare practitioner is to start with a first-line drug. If it doesn’t work, they may change the prescription after a month or two. This trial-and-error process can sometimes take two to three months before a patient finds the medication that truly works for them. But with pharmacogenomics (PGx), a GP can determine—before prescribing anything—which medication will work best for that individual.

Genetic Testing for Psychiatric Medications 2025

Published 03/03/2025

At AttoDiagnostics, our pharmacogenomics test covers over 20 conditions and 115 medications. Within the psychiatric space, depression, anxiety, bipolar disorder, schizophrenia, and ADHD are the main conditions we focus on. The benefits of PGx affect not only the patients directly, in terms faster and better treatment outcomes, but also UK as a whole: Using DNA-driven prescriptions could prevent 15% of hospital admissions, saving the NHS £530 annually.

NHS vs. Private: How to Get a Pharmacogenomic Test

Published 06/01/2025

Pharmacogenetic testing is revolutionising the way we approach medication by tailoring treatments to an individual’s genetic makeup. This can improve drug efficacy and reduce the risk of adverse side effects. But how can patients in the UK access pharmacogenetic testing? Here’s a breakdown of the pathways available through the NHS and private healthcare.

Unlocking the Power of Personalised Medicine with Pharmacogenomics

Published 26/11/2024

Many factors affect how well a medication works for you. Your ethnicity, age, weight, lifestyle, other medications, and overall health can all influence how your body responds to treatment. Among these influences, your genetic makeup has a significant part to play.

Unlocking the Power of PGx in Statin Therapy

Published 21/11/2024

Statins are the most frequently prescribed medications for reducing LDL cholesterol and managing cardiovascular conditions. They play a crucial role in preventing heart attacks and strokes. Despite their widespread use and proven efficacy, not all patients respond favourably to statins; some fail to achieve effective cholesterol reduction, while others experience adverse effects. For instance, both Lovastatin and Simvastatin have been associated with an increased risk of muscle and liver toxicity.

The Economic Benefits of Pharmacogenomics (PGx) Testing: Predicting Cost Savings in Healthcare

Published 13/11/2024

In the era of personalised medicine, pharmacogenomics (PGx) testing is gaining traction as a powerful tool for tailoring drug therapies to individual genetic profiles. While the primary focus of PGx testing is to improve patient outcomes by optimising drug efficacy and minimising adverse drug reactions (ADRs), there is growing evidence that it can also lead to significant cost savings in healthcare. This blog explores the economic benefits of PGx testing, drawing on several key studies that predict substantial savings through its implementation

Pharmacogenomic Testing (PGx) to Support Contraceptives

Published 04/11/2024

Finding the right contraceptive for an individual has always proven to be a difficult task as each person responds differently. Each person has a unique genetic makeup that affects how they metabolise or respond to various hormonal contraceptives. PGx testing helps identify the best contraceptive option for individuals by reducing side effects, improving efficacy, and minimising the time spent on finding a suitable method.

Are All PGx Tests Created Equal?

Published 24/10/2024

As pharmacogenomics (PGx) gains traction in personalised medicine, more healthcare providers are considering offering these tests to their patients. But with the growing number of PGx test providers, a critical question arises: Are all PGx tests created equal? Here’s what healthcare professionals should consider when selecting a PGx test provider.

How Pharmacogenomic Testing (PGx) Can Help in the Treatment of PMDD

Published 14/10/2024

Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome, popularly known as PMS. PMS is manageable and has mild symptoms, while PMDD is more severe, difficult to manage and characterised by intense emotional and physical symptoms.

Gene-Drug Interactions and Pharmacokinetics Explained

Published 10/10/2024

Pharmacogenomics (PGx) testing plays a pivotal role in this process, offering insights into gene-drug interactions that can optimise treatment strategies. A key component of this analysis is pharmacokinetics - the study of how drugs move through the body.

Understanding the Role of Pharmacogenetics in Modern Medicine

Published 04/10/2024

Pharmacogenetics or pharmacogenomics (PGx) is an exciting and growing field that explores the relationship between an individual’s genetic makeup and their response to medications. This personalised approach to treatment is paving the way for more personalised and effective medical care.

Which Antidepressants Are Least Associated with Weight Gain?

Published 01/10/2024

One of the most common concerns for individuals starting antidepressant therapy is the potential for weight gain. Searches like "which antidepressants cause the most weight gain" or "SSRI weight gain comparison" reveal just how prevalent this worry is.

Is ADHD Hereditary?

Published 30/09/2024

Although the exact causes of Attention deficit hyperactivity disorder (ADHD) are unknown, there are certain factors that play a role in an individual having it. These factors include genetics, pregnancy issues, neurobiological factors and environmental factors. A huge part of those factors is genetics.

Pharmacogenomic Testing for Bipolar Disorder

Published 17/09/2024

Bipolar Disorder (BP) is a mental health disorder that affects an individual’s moods causing them to have episodes or periods of extreme mood swings with symptoms of depression and/or mania.These mood swings can make it challenging for individuals to lead a normal life and perform everyday tasks

Using Pharmacogenomics (PGx) to Choose the Best Medication for ADHD

Published 11/09/2024

Choosing the best medication for ADHD (Attention- Deficit /Hyperactivity Disorder) can be a challenging task and careful evaluation of various factors such as the patient’s characteristics, side effects that could potentially arise and their response to any previous treatment is needed.

The Role of Genetics in Anticonvulsant and Antipsychotic Treatment

Published 23/08/2024

Anticonvulsants and antipsychotics are crucial medications used to manage conditions such as epilepsy, bipolar disorder, and schizophrenia. However, like many medications, their effectiveness and side effect profiles can vary widely from person to person.

The Role of Genetics in Citalopram and Sertraline Treatment

Published 22/08/2024

Citalopram and Sertraline are two of the most commonly prescribed antidepressants in the UK, often used to treat conditions like depression and anxiety. While these medications are effective for many people, their success can vary widely from person to person.

Understanding Common Adverse Drug Reactions (ADRs) in Mental Health Medications

Published 20/08/2024

Managing the side effects of psychotic and antipsychotic medications is a crucial aspect of patient care for GPs, Psychiatrists and Mental Health Professionals. Adverse drug reactions (ADRs) can significantly impact a patient's adherence to medication and overall quality of life, and with today's PGx testing, can be avoided.

How Ethnicity Plays a Role in Personalised Medicine

Published 19/08/2024

By understanding how an individual’s genetic makeup influences their response to medications, healthcare providers can tailor treatments to maximise effectiveness and minimise adverse effects. However, the efficacy and accuracy of these medications can vary significantly across different populations, primarily due to the differences in the availability and depth of research conducted on diverse ethnic groups.

The Role of Pharmacogenomics Testing in Antidepressant Treatment

Published 16/08/2024

In the complex world of mental health management, finding the right antidepressant can be a daunting task. What works wonders for one person might offer no relief or worse, cause significant side effects for another. However, recent advancements in pharmacogenomics offer a promising solution: personalised medicine tailored to your genetic makeup.

The Benefits of Pharmacogenomic (PGx) Testing for Psychiatric Prescriptions

Published 24/06/2024

In the realm of psychiatric care, prescribing the right medication is often a complex and challenging process. Many patients undergo a trial-and-error approach, trying different medications and dosages until an effective regimen is found. This process can be lengthy, costly, and distressing for patients and their families. At AttoDiagnostics, we believe that pharmacogenomic (PGx) testing offers a transformative solution to these challenges.

Why Methylation DNA Testing is an Interesting Alternative to Common

Published 24/06/2024

In the realm of genetic testing, methylation DNA testing has emerged as a promising alternative to traditional "health and wellness" DNA tests. Unlike conventional tests that focus on genetic predispositions, methylation testing provides insights into gene expression and the impact of environmental factors. One of the most compelling aspects of methylation testing is its ability to guide dietary modifications by identifying specific nutrient deficiencies and their effects on overall health.

Top 5 Psychiatric Medications Sensitive to Pharmacogenomic (PGx) Testing

Published 24/06/2024

Pharmacogenomic (PGx) testing is revolutionising the field of psychiatry by providing personalised insights into how patients metabolise and respond to medications. Here, we highlight five key psychiatric medications where PGx testing has significant implications for treatment efficacy and safety.

AttoDiagnostics’ Journey into Pharmacogenomics

Published 02/06/2024

Our pharmacogenetic (PGx) offering is uniquely ours. Explore our PGx products for mental health and ADHD, cardiology, and fertility, or ask about our broader services in genotyping, microbiome analysis, bloodborne virus screening, and research projects.